Busulfan-Cyclophosphamide versus Cyclophosphamide-Busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial

被引：0
|
作者：
Seydoux, C. [1 ]
Medinger, M. [1 ]
Gerull, S. [1 ]
Halter, J. [1 ]
Heim, D. [1 ]
Chalandon, Y. [2 ,3 ]
Levrat, Masouridi S. [2 ,3 ]
Schanz, U. [4 ]
Nair, G. [4 ]
Simon, P. [5 ]
Passweg, J. R. [1 ]
Cantoni, N. [6 ]
机构：
[1] Univ Hosp Basel, Div Hematol, Basel, Switzerland
[2] Univ Hosp Geneva, Bone Marrow Transplant Unit, Div Hematol, Geneva, Switzerland
[3] Univ Geneva, Fac Med, Geneva, Switzerland
[4] Univ Zurich, Stem Immune Cell Transplant Unit, Dept Med Oncol & Hematol, Zurich, Switzerland
[5] Basel Univ, Dept Clin Res, Clin Trials Unit, Basel, Switzerland
[6] Kantonsspital Aarau, Div Oncol Hematol & Transfus Med, Aarau, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [31] Regimen related toxicity after thiotepa, cyclophosphamide and intravenous busulfan as conditioning for allogeneic stem cell transplantation
    Sanz, J
    Sanz, GF
    Moscardó, F
    Cupelli, L
    Montesinos, P
    Puig, N
    Lorenzo, I
    Benlloch, L
    Jarque, I
    de la Rubia, J
    Martínez, J
    Martín, G
    Sanz, MA
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 33 - 34
  • [32] Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Lee, Kyoungmin
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Ryu, Jin-Sook
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [33] PRELIMINARY-RESULTS OF A NEW BUSULFAN-CYCLOPHOSPHAMIDE REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA
    COPELAN, E
    TUTSCHKA, P
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 217 - 217
  • [34] HEMATOPOIETIC RECONSTITUTION AFTER BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING AND ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SZCZYLIK, C
    RATAJCZAK, MZ
    URBANOWSKA, E
    WIKTORJEDRZEJCZAK, W
    BLUT, 1988, 57 (04): : 235 - 235
  • [35] COST EFFECTIVENESS ANALYSIS OF BUSULFAN plus CYCLOPHOSPHAMIDE (BUCY2) AS CONDITIONING REGIMEN BEFORE ALLOGENEIC HUMAN STEAM CELL TRANSPLANTATION (HSCT): COMPARISON OF ORAL VERSUS IV BUSULFAN
    Tellez Giron, G.
    Salgado, J. L.
    Soto, H.
    VALUE IN HEALTH, 2012, 15 (04) : A220 - A220
  • [36] ALLOGENEIC BONE-MARROW TRANSPLANTATION FOLLOWING BUSULFAN-CYCLOPHOSPHAMIDE WITH OR WITHOUT ETOPOSIDE CONDITIONING REGIMEN FOR PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    VONBUELTZINGSLOEWEN, A
    BELANGER, R
    PERREAULT, C
    BONNY, Y
    ROY, DC
    BOILEAU, J
    KASSIS, J
    LAVALLEE, R
    LACOMBE, M
    GYGER, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1993, 85 (04) : 706 - 713
  • [37] A modified busulfan and cyclophosphamide preparative regimen for allogeneic transplantation in myeloid malignancies
    Cai, Xiaojin
    Wei, Jialing
    He, Yi
    Yang, Dongling
    Jiang, Erlie
    Huang, Yong
    Han, Mingzhe
    Feng, Sizhou
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 44 - 52
  • [38] A modified busulfan and cyclophosphamide preparative regimen for allogeneic transplantation in myeloid malignancies
    Xiaojin Cai
    Jialing Wei
    Yi He
    Dongling Yang
    Erlie Jiang
    Yong Huang
    Mingzhe Han
    Sizhou Feng
    International Journal of Clinical Pharmacy, 2015, 37 : 44 - 52
  • [39] Randomized Trial of Busulfan with Cyclophosphamide Versus Busulfan with Fludarabine As Preparative Regimen to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia: A Study from the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
    Rambaldi, Alessandro
    Grassi, Anna
    Mico, Maria Caterina
    Busca, Alessandro
    Bruno, Benedetto
    Cavattoni, Irene
    Santarone, Stella
    Raimondi, Roberto
    Montanari, Mauro
    Milone, Giuseppe
    Chiusolo, Patrizia
    Specchia, Giorgina
    Guidi, Stefano
    Patriarca, Francesca
    Bacigalupo, Andrea
    Risitano, Antonio M.
    Saporiti, Giorgia
    Pini, Massimo
    Pogliani, Enrico Maria
    Arcese, William
    Marotta, Giuseppe
    Carella, Angelo Michele
    Nagler, Arnon
    Russo, Domenico
    Corradini, Paolo
    Alessandrino, Emilio Paolo
    Torelli, Giovanni Fernando
    Scime, Rosanna
    Mordini, Nicola
    Oldani, Elena
    Masciulli, Arianna
    Marfisi, Rosa Maria
    Bosi, Alberto
    BLOOD, 2014, 124 (21)
  • [40] Progenitor cell transplantation (PCT) in children with a conditioning regimen of busulfan, cyclophosphamide and etoposide.
    Mustafa, MM
    El Solh, H
    Ayas, M
    Al-Mahr, M
    Al-Jefri
    BLOOD, 1998, 92 (10) : 353B - 353B
12345